|
|
|
|
|
SAN FRANCISCO, CA, Sept 18, 2014 - (ACN Newswire) - Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), is pleased to announce that it has been selected as Capital Markets Advisor to Supreme Pharmaceuticals Inc. (CSE.SL). As part of the engagement, Merriman will act as Principal American Liaison (PAL) to Supreme in its US operations.
Supreme Pharmaceuticals, based in British Columbia, Canada, focuses on bringing sustainably grown medical marijuana to market in Canada. The Company has purchased a 342,000 square foot greenhouse growing facility in Southern Ontario and is upgrading the facility to the standards required by the Canadian federal Marihuana for Medical Purposes Regulations (MMPR).
Merriman's Capital Markets Advisory Group clients benefit from corporate brokerage services, access to unique capital solutions, and a range of related services intended to help unique public and private emerging growth companies accomplish their capital markets goals.
"We welcome Supreme Pharmaceuticals to our platform of Capital Markets Advisory clients," commented Douglas Rogers, Managing Director and Head of the Capital Markets Advisory Group at Merriman. Mr. Rogers continued, "Supreme has a unique market opportunity, executing its vertically integrated full suite of services for the medicinal marijuana industry within Canada."
About Merriman Capital, Inc.
Merriman Capital, Inc. is a full service investment bank and Broker-Dealer that facilitates efficient capital formation through a proprietary digital network, and offers Capital Markets Advisory and comprehensive Corporate Brokerage services for public and private companies. The firm also provides equity and options execution services for sophisticated investors and differentiated research for high growth companies. Merriman Capital, Inc. is a wholly owned brokerage subsidiary of Merriman Holdings, Inc. (OTCQX: MERR) and is a leading advisory firm for publicly traded, high-growth companies.
Digital Capital Network, powered by Merriman Capital, is a capital marketplace that enables highly targeted and more efficient execution of transactions. Please visit our website for more information on how you can be a part of our Digital Capital Network: http://www.digitalcapitalnetwork.com. Digital Capital Network, Inc. is a wholly owned subsidiary of Merriman Holdings, Inc. All operations on the Digital Capital Network are currently being executed by Merriman Capital, Inc.
Merriman Capital, Inc. is a registered broker-dealer and member of The Financial Industry Regulatory Authority (FINRA) http://www.finra.org/ and the Securities Investor Protection Corporation (SIPC) http://www.sipc.org/.
About Supreme Pharmaceuticals, Inc.
Supreme Pharmaceuticals Inc. ("Supreme") is a Canadian based medical marijuana company whose mission is to bring standardized, sustainable, high-quality, low-cost marijuana to Canadian patients for medical use. The company is based in Vancouver, British Columbia, with its primary operations in Kincardine, Ontario, a small, rural community near Toronto.
Note to Investors
This press release contains certain forward-looking statements based on our current expectations, forecasts and assumptions that involve risks and uncertainties. This release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity. Forward-looking statements in this release are based on information available to us as of the date hereof. Our actual results may differ materially from those stated or implied in such forward-looking statements, due to risks and uncertainties associated with our business, which include the risk factors disclosed in our Form 10-K filed on March 31, 2014. Forward-looking statements include statements regarding our expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," and "would" or similar words. We assume no obligation to update the information included in this press release, whether as a result of new information, future events or otherwise. The Form 10-K filed on March 31, 2014, together with this press release and the financial information contained herein, are available on our website, www.merrimanco.com. Please click on "Investor Relations."
At Merriman:
Alexandra Petek
Director of Client Services
Merriman Capital, Inc.
+1-415-248-5681
Howard Bernstein
Chief Compliance Officer
Merriman Capital, Inc.
+1-415-262-1377
###
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Merriman Holdings Inc. via Globenewswire
Topic: Press release summary
Source: Merriman Holdings Inc.
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
|
